Impel Pharmaceuticals
Kelly Fitzgerald is a seasoned sales professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as a Senior Territory Sales Manager at Impel Pharmaceuticals since 2023, Kelly previously held roles at Harmony Biosciences, AMAG Pharmaceuticals, and Shionogi Inc., focusing on rare diseases, neurological disorders, and maternal health. Notable achievements include leading business development strategies, training teams, and successfully launching new products, such as Osphena at Shionogi. Earlier career positions included significant roles at Aramark Uniform Services, Boehringer Ingelheim, and Pfizer, where Kelly consistently achieved top rankings and contributed to substantial sales growth. Kelly holds a degree from Lakehead University, earned between 1988 and 1992.
This person is not in any offices
Impel Pharmaceuticals
Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.